CHAPTER 13: ANTI-MICROBIAL
RESISTANCE
Points to be covered in this topic
➤ Introduction
➤ Anti-Microbial Resistance
➤ Mechanisms of resistance
➤ Examples
➤ Causes
➤ Prevention
13.1 Introduction
Antimicrobial resistance (AMR) is a significant and
growing global health concern that poses a threat to the
effective prevention and treatment of a wide range of
infections
caused by bacteria, viruses, parasites, and fungi. AMR
occurs when microorganisms, such as bacteria, viruses, fungi, and parasites, evolve
and develop resistance to the drugs designed to kill or inhibit their growth. This
renders standard treatment protocols ineffective, leading to persistent infections,
increased healthcare costs, and a higher risk of spread of infections to others.
13.2 Anti-Microbial Resistance: A Global Concern
Antimicrobial medications serve as the foundation of
contemporary medicine, playing a crucial role in treating
common infections and facilitating life-saving medical
procedures, such as cancer chemotherapy, caesarean sections,
hip replacements, organ transplants, and various surgeries.
However, the emergence and dissemination of drug-resistant pathogens pose a
severe threat to our ability to effectively address these medical challenges.
Moreover, the repercussions of drug-resistant infections extend beyond human
health, affecting animals and plants. This phenomenon hampers agricultural
productivity, diminishes farm output, and jeopardizes global food security. The
consequences of antimicrobial resistance (AMR) are substantial, impacting both
health systems and national economies. The need for costlier and intensive care,
prolonged hospital stays, and decreased productivity among patients and caregivers
are some of the direct effects.
13.3 Mechanisms of resistance to anti-microbial agents
Microorganisms including bacteria, viruses, parasites, and fungi use a range of
tactics known as mechanisms of resistance to antimicrobial medicines to avoid the
effects of medications used to treat them. These mechanisms can arise
spontaneously, or they can be acquired by resistant gene transfer or genetic
mutation.
The following are a few typical resistance mechanisms:
1. Genetic Mutations
(a) Target Modification: Microorganisms can undergo genetic
mutations that alter the target sites of antimicrobial agents.
For example, mutations in bacterial DNA gyrase can reduce
the binding affinity of fluoroquinolone antibiotics.
(b) Enzyme Modification: Genetic changes can lead to the production of modified
enzymes that can deactivate or modify the antimicrobial agent. Beta-lactamase
enzymes, produced by some bacteria, can hydrolyze beta-lactam antibiotics like
penicillins.
2. Efflux Pumps
(a) Some microorganisms possess efflux pumps that actively pump out
antimicrobial agents from within the cell, reducing the intracellular concentration of
the drug and diminishing its effectiveness. This mechanism is commonly observed
in bacteria.
3. Biofilm Formation
(a) Microorganisms can form biofilms, which are structured communities of cells
surrounded by a protective matrix. Biofilms can act as a barrier, preventing
antimicrobial agents from reaching and affecting the microbial cells within.
4. Horizontal Gene Transfer
(a) Resistance genes can be transferred horizontally between different species of
microorganisms. This can occur through processes such as conjugation,
transformation, and transduction, facilitating the rapid spread of resistance traits
within microbial populations.
5. Reduced Permeability
(a) Microorganisms can develop mechanisms to reduce the permeability of their
cell membranes, limiting the entry of antimicrobial agents into the cell. This is
commonly seen in bacteria, where changes in membrane proteins can restrict the
passage of drugs.
6. Alternative Metabolic Pathways
(a) Some microorganisms can bypass the target pathway of antimicrobial agents by
utilizing alternative metabolic pathways. This allows them to survive and replicate
in the presence of drugs that would otherwise inhibit their growth.
7. Inactivation of Drugs
(a) Microorganisms can produce enzymes that chemically modify or degrade
antimicrobial agents, rendering them inactive. For example, acetyltransferases can
modify aminoglycoside antibiotics, reducing their efficacy.
8. Persisters and Dormancy
(a) Some microorganisms can enter a dormant or persister state, where they become
less susceptible to the effects of antimicrobial agents. This dormancy allows them
to survive exposure to drugs and later resume active growth.
13.4 Some examples of antimicrobial resistance
1. Methicillin-resistant Staphylococcus aureus (MRSA):
MRSA is a type of bacteria that has become resistant to many of the antibiotics
commonly used to treat Staphylococcus aureus infections. This includes methicillin
and other beta-lactam antibiotics.
2. Multidrug-resistant Tuberculosis (MDR-TB):
Tuberculosis (TB) is caused by Mycobacterium tuberculosis. MDR-TB is a form of
TB that is resistant to at least two of the most powerful first-line anti-TB drugs,
isoniazid and rifampicin.
3. Extended-Spectrum Beta-Lactamase (ESBL)-producing Enterobacteriaceae:
Enterobacteriaceae are a family of bacteria that includes E. coli and Klebsiella.
Some strains have developed resistance to a broad range of beta-lactam antibiotics,
which are commonly used to treat bacterial infections.
4. Carbapenem-resistant Enterobacteriaceae (CRE):
Enterobacteriaceae that are resistant to carbapenem antibiotics, which are often
considered as the last resort for treating multidrug-resistant bacterial infections.
5. Fluoroquinolone-resistant Neisseria gonorrhoeae:
Neisseria gonorrhoeae is the bacterium that causes gonorrhea. Resistance to
fluoroquinolone antibiotics has been observed in some strains, limiting treatment
options for this sexually transmitted infection.
6. Antiretroviral drug resistance in HIV:
The human immunodeficiency virus (HIV) can develop resistance to antiretroviral
drugs used in the treatment of HIV/AIDS. This resistance can complicate the
management of HIV infections.
7. Antifungal resistance:
Fungal infections can also become resistant to antifungal medications. For example,
Candida species, which can cause various infections, may develop resistance to
commonly used antifungal drugs.
13.5 Causes of anti-microbial resistance
The complex interactions between microbes, antimicrobial
agents, and other environmental and human variables lead to
the diverse causes of antimicrobial resistance (AMR). To
effectively adopt methods to prevent the formation and spread
of antimicrobial resistance (AMR), it is imperative to have a
thorough understanding of these reasons. The following are
the main causes of antibiotic resistance:
1. Overuse and Misuse of Antibiotics
(a) Inappropriate Prescribing: Over prescription and inappropriate use of antibiotics
by healthcare professionals can contribute significantly to the development of
resistance.
(a) Self-Medication: Patients using antibiotics without proper medical guidance or
not completing prescribed courses can also contribute to the emergence of resistant
strains.
2. Incomplete Treatment Courses
Failing to complete a prescribed course of antibiotics can allow surviving microbes
to develop resistance. Inadequate treatment may not fully eliminate the infection,
providing an opportunity for resistant strains to proliferate.
3. Non-Adherence to Prescription Guidelines
Failure to adhere to recommended dosages and schedules can undermine the
effectiveness of antibiotics and contribute to the development of resistance.
4. Use in Agriculture and Livestock
(a) Inappropriate Agricultural Practices: The use of antimicrobials in agriculture for
growth promotion or disease prevention in animals can contribute to the spread of
resistant microorganisms.
(b) Antibiotic Use in Aquaculture: The use of antibiotics in aquaculture can lead to
the development of resistant strains in aquatic environments.
5. Globalization and Travel
Increased international travel and trade facilitate the global spread of resistant
microorganisms. Resistant strains can move across borders, making containment
and control challenging.
6. Lack of Access to Clean Water, Sanitation, and Hygiene (WASH)
Poor sanitation and hygiene conditions contribute to the spread of infections,
leading to increased antibiotic use and the potential for the development of
resistance.
7. Lack of Surveillance and Monitoring
Inadequate systems for monitoring and tracking antibiotic use and resistance
patterns hinder the ability to implement targeted interventions and control
measures.
8. Lack of New Antibiotic Development
The slow pace of new antibiotic development limits treatment options, and the
emergence of resistance outpaces the discovery of effective drugs.
9. Global Trade of Food and Animals
The international trade of food products and animals can contribute to the spread of
resistant strains through contaminated food products or carriers.
10. Lack of Awareness and Education
Limited awareness among healthcare professionals, patients, and the general public
about the consequences of antibiotic misuse and the importance of responsible use.
13.6 Prevention of anti-microbial resistance
Antimicrobial resistance (AMR) prevention is a complicated
and multidimensional issue that calls for coordinated efforts
across numerous industries. Strategies at the individual,
community, healthcare, and policy levels are all part of a
complete approach.
1. Responsible Antibiotic Use
(a) Medical practitioners should only prescribe antibiotics sparingly, in accordance
with proper indications and precise diagnosis.
(b) Patients should strictly adhere to the recommended antibiotic regimens, even if
their symptoms subside before the medication's full course is finished.
2. Antimicrobial Stewardship Programs
Implement antimicrobial stewardship programs in healthcare settings to optimize
the use of antimicrobials, reduce unnecessary prescriptions, and minimize the
development of resistance.
3. Surveillance and Monitoring
Establishing robust systems for monitoring antibiotic use and resistance patterns to
identify emerging threats and implement targeted interventions.
4. Infection Prevention and Control
Adhering to strict infection prevention and control measures in healthcare facilities
to reduce the transmission of resistant microorganisms.
5. Vaccination Programs
Boosting and expanding immunization campaigns to stop the spread of infectious
diseases and lower the demand for antibiotic therapy.
6. Research and Development
Investing in research and development to discover new antimicrobial agents and
alternative treatment approaches.
7. One Health Approach
Adopting a One Health approach that recognizes the interconnectedness of human
health, animal health, and the environment. Coordinated efforts across sectors can
address the complex factors contributing to AMR.
8. Regulatory Measures
Implementing and enforcing regulations on the use of antibiotics in human
healthcare, agriculture, and veterinary practices to curb inappropriate use.
9. Global Collaboration
Collaborating at the international level to share data, knowledge, and best practices.
Global cooperation is essential to address AMR, as resistant microorganisms can
cross borders.
10. Promotion of Research and Innovation
Encouraging and supporting research and innovation for the development of new
diagnostic tools, vaccines, and antimicrobial agents.
11. Raising Animal Welfare Standards
Improving animal welfare standards in agriculture to reduce the need for
prophylactic use of antibiotics in livestock.